Alzheimer disease is a progressive neurodegenerative disease in which patients have declarative memory impairments and increasingly severe dementia. Numerous pathological changes have been described ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment ...

A research team has identified a molecular mechanism that coordinates the operation of the N-methyl-D-aspartate (NMDA) glutamate receptor, which is key to regulating excitatory synapse function in the ...

Investigadores del Instituto de Neurociencias de la Universidad Miguel Hernández de Elche y el Consejo Superior de Investigaciones Científicas, han desarrollado un protocolo de fraccionamiento celular ...

It remains difficult to distinguish anti-NMDA receptor encephalitis from a primary psychiatric disorder, but recent studies have identified clinical features and proposed screening criteria that could ...

For all glutamate-gated channels, agonist-binding in the cleft formed by two dynamic lobes, D1 and D2, of ligand-binding domains (LBDs) is the event that energizes resting receptors to either open or ...

D epression can be challenging to treat. Typical antidepressants, which affect levels of chemicals in the brain involved in mood regulation, have been evolving for decades. But recent findings ...

El investigador Antonio Rodríguez-Moreno, del departamento de Fisiología, Anatomía y Biología Celular de la Universidad Pablo de Olavide, en colaboración con el investigador Ole Paulsen, del ...

Regístrate gratis en Diario Médico. Para seguir leyendo Diario Médico necesitamos saber tu perfil profesional. Así podremos garantizarte que estás dentro de un portal para profesionales relacionados ...

Un estudio llevado a cabo por neurocientíficos del Instituto Picower para el Aprendizaje y la Memoria del MIT presenta una nueva estrategia para tratar la patología y los síntomas del síndrome de X ...